Fresenius Medical Care Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration With Lower Mortality Risk Than Conventional Hemodialysis
August 28, 2026
August 28, 2026
BAD HOMBURG, Germany, Aug. 28 (TNSjou) -- Fresenius Medical Care, a provider of products and services for people with chronic kidney failure, issued the following news release:
* * *
Fresenius Medical Care Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration with Lower Mortality Risk Than Conventional Hemodialysis
* Publication in the Journal of the American Society of Nephrology reports that, in a lar . . .
* * *
Fresenius Medical Care Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration with Lower Mortality Risk Than Conventional Hemodialysis
* Publication in the Journal of the American Society of Nephrology reports that, in a lar . . .